USD 0.49
(-2.65%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 1.79 Million USD | -56.25% |
2022 | 4.11 Million USD | -73.52% |
2021 | 15.51 Million USD | -48.93% |
2020 | 30.38 Million USD | 113.73% |
2019 | 14.21 Million USD | 184.52% |
2018 | 4.99 Million USD | 193.88% |
2017 | 1.7 Million USD | 36.91% |
2016 | 1.24 Million USD | 20.51% |
2015 | 1.03 Million USD | 191.66% |
2014 | 353.33 Thousand USD | 0.37% |
2013 | 352.05 Thousand USD | 8.26% |
2012 | 325.2 Thousand USD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q1 | 1.58 Million USD | -11.62% |
2024 Q2 | 3.1 Million USD | 95.53% |
2023 Q3 | 3.15 Million USD | -22.12% |
2023 Q4 | 1.79 Million USD | -42.99% |
2023 FY | 1.79 Million USD | -56.25% |
2023 Q1 | 5.19 Million USD | 26.45% |
2023 Q2 | 4.05 Million USD | -22.07% |
2022 Q3 | 5.01 Million USD | -47.71% |
2022 Q4 | 4.11 Million USD | -18.05% |
2022 Q1 | 12.54 Million USD | -19.18% |
2022 FY | 4.11 Million USD | -73.52% |
2022 Q2 | 9.59 Million USD | -23.54% |
2021 FY | 15.51 Million USD | -48.93% |
2021 Q3 | 21.67 Million USD | 20.23% |
2021 Q4 | 15.51 Million USD | -28.39% |
2021 Q1 | 24.51 Million USD | -19.32% |
2021 Q2 | 18.02 Million USD | -26.47% |
2020 FY | 30.38 Million USD | 113.73% |
2020 Q1 | 17.84 Million USD | 25.49% |
2020 Q2 | 39.81 Million USD | 123.15% |
2020 Q3 | 34.95 Million USD | -12.2% |
2020 Q4 | 30.38 Million USD | -13.07% |
2019 Q2 | 12.06 Million USD | 1.33% |
2019 FY | 14.21 Million USD | 184.52% |
2019 Q1 | 11.9 Million USD | 138.23% |
2019 Q3 | 14.22 Million USD | 17.9% |
2019 Q4 | 14.21 Million USD | -0.03% |
2018 Q3 | 7.74 Million USD | 85.45% |
2018 FY | 4.99 Million USD | 193.88% |
2018 Q4 | 4.99 Million USD | -35.51% |
2018 Q2 | 4.17 Million USD | 249.27% |
2018 Q1 | 1.19 Million USD | -29.65% |
2017 Q1 | 1.45 Million USD | 17.25% |
2017 Q2 | 1.09 Million USD | -24.48% |
2017 Q3 | 423.1 Thousand USD | -61.53% |
2017 Q4 | 1.7 Million USD | 301.87% |
2017 FY | 1.7 Million USD | 36.91% |
2016 Q1 | 192.01 Thousand USD | -81.37% |
2016 FY | 1.24 Million USD | 20.51% |
2016 Q3 | 335.28 Thousand USD | -62.46% |
2016 Q4 | 1.24 Million USD | 270.42% |
2016 Q2 | 893.21 Thousand USD | 365.18% |
2015 Q1 | 2.25 Million USD | 538.75% |
2015 Q4 | 1.03 Million USD | 78.47% |
2015 Q3 | 577.45 Thousand USD | -58.49% |
2015 Q2 | 1.39 Million USD | -38.37% |
2015 FY | 1.03 Million USD | 191.66% |
2014 Q2 | 105.29 Thousand USD | 92.42% |
2014 Q3 | 410.94 Thousand USD | 290.29% |
2014 Q4 | 353.33 Thousand USD | -14.02% |
2014 Q1 | 54.72 Thousand USD | -84.46% |
2014 FY | 353.33 Thousand USD | 0.37% |
2013 Q3 | 139.98 Thousand USD | -63.35% |
2013 Q1 | 750.22 Thousand USD | 130.69% |
2013 Q2 | 381.96 Thousand USD | -49.09% |
2013 FY | 352.05 Thousand USD | 8.26% |
2013 Q4 | 352.05 Thousand USD | 151.5% |
2012 Q4 | 325.2 Thousand USD | 0.0% |
2012 FY | 325.2 Thousand USD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Accelerate Diagnostics, Inc. | 31.36 Million USD | 94.268% |
BrainsWay Ltd. | 62.97 Million USD | 97.145% |
Cerus Corporation | 197.74 Million USD | 99.091% |
Envoy Medical, Inc. | 7.64 Million USD | 76.466% |
electroCore, Inc. | 16.38 Million USD | 89.028% |
Helius Medical Technologies, Inc. | 7.69 Million USD | 76.625% |
IceCure Medical Ltd | 16.41 Million USD | 89.043% |
Inogen, Inc. | 326.19 Million USD | 99.449% |
OrthoPediatrics Corp. | 449.58 Million USD | 99.6% |
Lucid Diagnostics Inc. | 27.27 Million USD | 93.407% |
Monogram Orthopaedics, Inc. | 16.57 Million USD | 89.155% |
MaxCyte, Inc. | 268.27 Million USD | 99.33% |
NeuroOne Medical Technologies Corporation | 8.09 Million USD | 77.795% |
Nexalin Technology, Inc. | 3.63 Million USD | 50.494% |
Orthofix Medical Inc. | 925.31 Million USD | 99.806% |
PAVmed Inc | 33.11 Million USD | 94.571% |
Rapid Micro Biosystems, Inc. | 143.45 Million USD | 98.747% |
RxSight, Inc. | 182.55 Million USD | 99.015% |
Sight Sciences, Inc. | 166.65 Million USD | 98.921% |
SI-BONE, Inc. | 230.42 Million USD | 99.22% |
TELA Bio, Inc. | 78.04 Million USD | 97.696% |
Treace Medical Concepts, Inc. | 251.9 Million USD | 99.286% |
Vivos Therapeutics, Inc. | 10.73 Million USD | 83.243% |
Acutus Medical, Inc. | 53.96 Million USD | 96.668% |
Talis Biomedical Corporation | 98.34 Million USD | 98.172% |
Spectral AI, Inc. | 10.69 Million USD | 83.184% |
Nano-X Imaging Ltd. | 218.64 Million USD | 99.178% |
CVRx, Inc. | 115.22 Million USD | 98.44% |
DIH Holding US, Inc. Warrants | 58.66 Million USD | 96.935% |
PetVivo Holdings, Inc. | 3.11 Million USD | 42.284% |
Bioventus Inc. | 810.91 Million USD | 99.778% |
Venus Concept Inc. | 93.65 Million USD | 98.08% |
TriSalus Life Sciences, Inc. | 25.72 Million USD | 93.011% |
LivaNova PLC | 2.42 Billion USD | 99.926% |
908 Devices Inc. | 202.98 Million USD | 99.114% |
Alphatec Holdings, Inc. | 805.2 Million USD | 99.777% |
Nemaura Medical Inc. | 14.56 Million USD | 87.654% |
NeuroPace, Inc. | 107.65 Million USD | 98.33% |
LENSAR, Inc. | 69.58 Million USD | 97.416% |
Apyx Medical Corporation | 79.24 Million USD | 97.731% |
Cutera, Inc. | 346.29 Million USD | 99.481% |
STRATA Skin Sciences, Inc. | 42.01 Million USD | 95.721% |
Anika Therapeutics, Inc. | 270.63 Million USD | 99.336% |
ClearPoint Neuro, Inc. | 42.66 Million USD | 95.785% |
Integra LifeSciences Holdings Corporation | 3.78 Billion USD | 99.952% |
Axonics, Inc. | 719.92 Million USD | 99.75% |
Outset Medical, Inc. | 313.8 Million USD | 99.427% |
IRIDEX Corporation | 34.43 Million USD | 94.779% |
PROCEPT BioRobotics Corporation | 404.71 Million USD | 99.556% |
IRadimed Corporation | 92.15 Million USD | 98.049% |
Tivic Health Systems, Inc. | 5.25 Million USD | 65.778% |
INVO Bioscience, Inc. | 20.88 Million USD | 91.392% |
Telesis Bio, Inc. | 70.41 Million USD | 97.446% |
Viemed Healthcare, Inc. | 154.1 Million USD | 98.833% |
Varex Imaging Corporation | 1.24 Billion USD | 99.856% |
Quipt Home Medical Corp. | 247.4 Million USD | 99.273% |
Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | 80.687% |
Pulmonx Corporation | 178.95 Million USD | 98.995% |
Dynatronics Corporation | 25.94 Million USD | 93.069% |
Modular Medical, Inc. | 13.8 Million USD | 86.978% |
ReShape Lifesciences Inc. | 10.72 Million USD | 83.239% |
Semler Scientific, Inc. | 78.06 Million USD | 97.697% |
InMode Ltd. | 863.28 Million USD | 99.792% |
Bruker Corporation | 4.24 Billion USD | 99.958% |
Cytosorbents Corporation | 53.26 Million USD | 96.624% |
DexCom, Inc. | 6.26 Billion USD | 99.971% |
Align Technology, Inc. | 6.08 Billion USD | 99.97% |
Viveve Medical, Inc. | 25.91 Million USD | 93.061% |
ZimVie Inc. | 1.2 Billion USD | 99.851% |
Movano Inc. | 9.42 Million USD | 80.915% |
Cytek Biosciences, Inc. | 497.66 Million USD | 99.639% |
Nexalin Technology, Inc. | 3.63 Million USD | 50.494% |
DIH Holdings US, Inc. Class A Common Stock | 58.66 Million USD | 96.935% |
Tandem Diabetes Care, Inc. | 952.65 Million USD | 99.811% |
Profound Medical Corp. | 43.68 Million USD | 95.884% |
Insulet Corporation | 2.58 Billion USD | 99.931% |
enVVeno Medical Corporation | 48.63 Million USD | 96.303% |
Surmodics, Inc. | 185.73 Million USD | 99.032% |
iCAD, Inc. | 41.41 Million USD | 95.659% |
Nuwellis, Inc. | 9.77 Million USD | 81.597% |
Biotricity, Inc. | 5.94 Million USD | 69.744% |
iRhythm Technologies, Inc. | 433.14 Million USD | 99.585% |
Aethlon Medical, Inc. | 8.24 Million USD | 78.195% |
InspireMD, Inc. | 47.64 Million USD | 96.226% |
PAVmed Inc. | 33.11 Million USD | 94.571% |
BIOLASE, Inc. | 35.1 Million USD | 94.878% |
Beyond Air, Inc. | 56.96 Million USD | 96.843% |
FONAR Corporation | 214.24 Million USD | 99.161% |
AxoGen, Inc. | 196.82 Million USD | 99.087% |
Vivani Medical, Inc. | 45.79 Million USD | 96.074% |
Tactile Systems Technology, Inc. | 281.43 Million USD | 99.361% |
Inari Medical, Inc. | 674.23 Million USD | 99.733% |
UFP Technologies, Inc. | 404.13 Million USD | 99.555% |
QT Imaging Holdings, Inc. | 23.39 Million USD | 92.316% |
Heart Test Laboratories, Inc. | 9.5 Million USD | 81.08% |
Tenon Medical, Inc. | 6.34 Million USD | 71.663% |
Autonomix Medical, Inc. Common Stock | 9.4 Million USD | 80.887% |
Co-Diagnostics, Inc. | 103.64 Million USD | 98.265% |
AdaptHealth Corp. | 4.61 Billion USD | 99.961% |
Sintx Technologies, Inc. | 15.36 Million USD | 88.298% |
NanoVibronix, Inc. | 6.67 Million USD | 73.06% |
Quanterix Corporation | 425.01 Million USD | 99.577% |
Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | 80.687% |
Sensus Healthcare, Inc. | 53.72 Million USD | 96.653% |
Pacific Biosciences of California, Inc. | 1.74 Billion USD | 99.897% |
TransMedics Group, Inc. | 706.04 Million USD | 99.745% |
ReWalk Robotics Ltd. | 63.19 Million USD | 97.155% |
NeuroMetrix, Inc. | 21.42 Million USD | 91.608% |
Hyperfine, Inc. | 94.19 Million USD | 98.091% |
Establishment Labs Holdings Inc. | 268.64 Million USD | 99.331% |
Biomerica, Inc. | 9.25 Million USD | 80.571% |
Bone Biologics Corporation | 3.73 Million USD | 51.896% |
AVITA Medical, Inc. | 144.33 Million USD | 98.754% |
Bluejay Diagnostics, Inc. | 4.86 Million USD | 63.069% |
Silk Road Medical, Inc | 265.3 Million USD | 99.322% |